Bill Snyder Archive — Page 59 of 119
-
January 31, 2019
Destructive ‘telegrams’ in asthma
Vanderbilt investigators have discovered that certain microRNAs — "telegram"-like signals — increase after the induction of allergic airway inflammation. -
January 31, 2019
Designing antibodies to fight the flu
Vanderbilt investigators said their work shows that computational design can improve the ability of naturally occurring antibodies to recognize different flu strains and may hasten the development of more effective flu therapies and vaccines. -
January 31, 2019
Research bolsters thyroid function, atrial fibrillation link
A study by researchers at Vanderbilt University Medical Center has strengthened the link between thyroid function and atrial fibrillation (AF), an irregular heart rhythm that increases the risk of stroke and other heart-related complications. -
January 24, 2019
Vanderbilt Prize winner Amon to speak at Jan. 31 lecture
Angelika Amon, PhD, recipient of the 2018 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize lecture at 4 p.m. Thursday, Jan. 31, in 208 Light Hall. -
January 24, 2019
American Chemical Society honors Lindsley’s research
The year is starting off with a bang for Craig Lindsley, PhD, director of medicinal chemistry in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD). -
January 24, 2019
VUMC scientists ‘sprint’ to find anti-Zika antibodies
Scientists at Vanderbilt University Medical Center and colleagues in Boston, Seattle and St. Louis are racing to develop — in a mere 90 days — a protective antibody-based treatment that can stop the spread of the Zika virus.